$AMLX Balance Sheet | Understand Stock

$AMLX

$27.09 -$0.11 (0.4%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Short-term investments
Accounts receivable, net
Inventories
Deferred offering costs
Prepaid expenses and other current assets
Total current assets

Property and equipment, net
Restricted cash
Restricted cash equivalents
Operating lease right-of-use assets
Long-term inventories
Other assets
Deposits And Other Assets
Total assets
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Accrued expenses
Operating lease liabilities, current portion
Total current liabilities
Operating lease liabilities, net of current portion
Total liabilities
Stockholders' equity:
Common stock, $0.0001 par value; 300,000,000 shares authorized; 111,368,283 and 109,884,502 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders' equity
Total liabilities and stockholders' equity

Comments